{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:57:57Z","timestamp":1790697477804,"version":"4.1.0"},"reference-count":47,"publisher":"IMR Press","issue":"9","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Fund of China","award":["82200441"],"award-info":[{"award-number":["82200441"]}]},{"name":"National Natural Science Fund of China","award":["81970291"],"award-info":[{"award-number":["81970291"]}]},{"name":"National Natural Science Fund of China","award":["82170344"],"award-info":[{"award-number":["82170344"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Background: This large-scale cohort study aimed to evaluate the prognostic role of the systemic immune-inflammation index (SII) in patients with chronic total occlusion (CTO) undergoing percutaneous coronary intervention (PCI). Methods: A total of 3107 patients with CTO lesions who underwent PCI were enrolled in this study. Clinical characteristics were collected, and post-discharge major adverse cardiovascular events (MACEs) were recorded during follow-up, including all-cause mortality, non-fatal myocardial infarction, unplanned revascularization, and heart failure-related readmission. Patients were stratified into three groups according to SII tertiles: the low SII group (SII \u2264447.66, n = 1036), the intermediate SII group (447.66 &lt; SII &lt; 679.89, n = 1039), and the high SII group (SII \u2265679.89, n = 1032). Results: Over a median follow-up of 2.58 (2.33\u20132.92) years, 356 (11.5%) MACEs occurred, including 49 (1.6%) all-cause deaths, 105 (3.4%) non-fatal myocardial infarctions, 164 (5.3%) revascularizations, and 38 (1.2%) heart failure rehospitalizations. Multivariable Cox regression analyses demonstrated that elevated SII was independently linked to higher risks of MACEs (hazard ratio [HR] = 1.51, 95% confidence interval [CI]: 1.20\u20131.90; p = 0.001), all-cause death (HR = 2.06, 95% CI: 1.11\u20133.84; p = 0.022), non-fatal myocardial infarction (HR = 1.76, 95% CI: 1.15\u20132.69; p = 0.009), and repeat revascularization (HR = 1.32, 95% CI: 1.01\u20131.76; p = 0.046) after full adjustment. Kaplan\u2013Meier survival curves showed significantly higher rates of adverse events in patients with elevated SII. Adding SII to traditional risk models improved predictive performance, as reflected by increases in the concordance index (C-index), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Conclusions: Baseline SII is a reliable and independent predictor of MACEs in patients with CTO after PCI, with superior predictive performance compared with conventional inflammatory markers.<\/jats:p>","DOI":"10.31083\/rcm52837","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:57:11Z","timestamp":1790693831000},"source":"Crossref","is-referenced-by-count":0,"title":["Predictive Value of the Systemic Immune-Inflammation Index for Cardiovascular Events in Patients With Chronic Total Coronary Occlusion"],"prefix":"10.31083","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0549-8138","authenticated-orcid":true,"given":"Yuhao","family":"Zhao","sequence":"first","affiliation":[{"name":"Center for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Center for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Ma","sequence":"additional","affiliation":[{"name":"Center for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Zheng","sequence":"additional","affiliation":[{"name":"Center for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Shi","sequence":"additional","affiliation":[{"name":"Center for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Liu","sequence":"additional","affiliation":[{"name":"Center for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet (London, England). 2020; 395: 795\u2013808.","DOI":"10.1016\/S0140-6736(19)32008-2"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Kandzari DE, Lembo NJ, Carlson HD, Kalynych A, Spertus JA, Gibson CM, et al. Procedural, clinical, and health status outcomes in chronic total coronary occlusion revascularization: Results from the PERSPECTIVE study. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography & Interventions. 2020; 96: 567\u2013576.","DOI":"10.1002\/ccd.28494"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Vanhaverbeke M, Eertmans W, Holvoet W, Hendrickx I, McCutcheon K, Dubois C, et al. Contemporary Strategies and Outcomes of Dedicated Chronic Total Occlusion Percutaneous Coronary Intervention Programs: A Prospective Multicentre Registry. Journal of Interventional Cardiology. 2021; 2021: 8042633.","DOI":"10.1155\/2021\/8042633"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Hirai T, Grantham JA, Sapontis J, Cohen DJ, Marso SP, Lombardi W, et al. Quality of Life Changes After Chronic Total Occlusion Angioplasty in Patients With Baseline Refractory Angina. Circulation. Cardiovascular Interventions. 2019; 12: e007558.","DOI":"10.1161\/CIRCINTERVENTIONS.118.007558"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Rossello X, Pujadas S, Serra A, Bajo E, Carreras F, Barros A, et al. Assessment of Inducible Myocardial Ischemia, Quality of Life, and Functional Status After Successful Percutaneous Revascularization in Patients With Chronic Total Coronary Occlusion. The American Journal of Cardiology. 2016; 117: 720\u2013726.","DOI":"10.1016\/j.amjcard.2015.12.001"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Park TK, Lee SH, Choi KH, Lee JM, Yang JH, Song YB, et al. Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10-Year Follow-Up Study. Journal of the American Heart Association. 2021; 10: e019022.","DOI":"10.1161\/JAHA.120.019022"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Libby P. The changing landscape of atherosclerosis. Nature. 2021; 592: 524\u2013533.","DOI":"10.1038\/s41586-021-03392-8"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Libby P. Inflammation in Atherosclerosis-No Longer a Theory. Clinical Chemistry. 2021; 67: 131\u2013142.","DOI":"10.1093\/clinchem\/hvaa275"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Wolf D, Ley K. Immunity and Inflammation in Atherosclerosis. Circulation Research. 2019; 124: 315\u2013327.","DOI":"10.1161\/CIRCRESAHA.118.313591"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Sreejit G, Johnson J, Jaggers RM, Dahdah A, Murphy AJ, Hanssen NMJ, et al. Neutrophils in cardiovascular disease: warmongers, peacemakers, or both? Cardiovascular Research. 2022; 118: 2596\u20132609.","DOI":"10.1093\/cvr\/cvab302"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Silvestre-Roig C, Braster Q, Ortega-Gomez A, Soehnlein O. Neutrophils as regulators of cardiovascular inflammation. Nature Reviews. Cardiology. 2020; 17: 327\u2013340.","DOI":"10.1038\/s41569-019-0326-7"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Daub K, Langer H, Seizer P, Stellos K, May AE, Goyal P, et al. Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. 2006; 20: 2559\u20132561.","DOI":"10.1096\/fj.06-6265fje"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Massberg S, Schulz C, Gawaz M. Role of platelets in the pathophysiology of acute coronary syndrome. Seminars in Vascular Medicine. 2003; 3: 147\u2013162.","DOI":"10.1055\/s-2003-40673"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Trakarnwijitr I, Li B, Adams H, Layland J, Garlick J, Wilson A. Age modulates the relationship between platelet-to-lymphocyte ratio and coronary artery disease. International Journal of Cardiology. 2017; 248: 349\u2013354.","DOI":"10.1016\/j.ijcard.2017.06.127"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Wang X, Zhang G, Jiang X, Zhu H, Lu Z, Xu L. Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. Atherosclerosis. 2014; 234: 206\u2013213.","DOI":"10.1016\/j.atherosclerosis.2014.03.003"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Ye Z, Hu T, Wang J, Xiao R, Liao X, Liu M, et al. Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 2022; 9: 933913.","DOI":"10.3389\/fcvm.2022.933913"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Ybarra LF, Rinfret S, Brilakis ES, Karmpaliotis D, Azzalini L, Grantham JA, et al. Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations. Circulation. 2021; 143: 479\u2013500.","DOI":"10.1161\/CIRCULATIONAHA.120.046754"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Brilakis ES, Mashayekhi K, Tsuchikane E, Abi Rafeh N, Alaswad K, Araya M, et al. Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention. Circulation. 2019; 140: 420\u2013433.","DOI":"10.1161\/CIRCULATIONAHA.119.039797"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018; 138: e618\u2013e651.","DOI":"10.1161\/CIR.0000000000000617"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine. 2005; 352: 1685\u20131695.","DOI":"10.1056\/NEJMra043430"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Witztum JL, Lichtman AH. The influence of innate and adaptive immune responses on atherosclerosis. Annual Review of Pathology. 2014; 9: 73\u2013102.","DOI":"10.1146\/annurev-pathol-020712-163936"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Meng H, Yalavarthi S, Kanthi Y, Mazza LF, Elfline MA, Luke CE, et al. In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis. Arthritis & Rheumatology (Hoboken, N.J.). 2017; 69: 655\u2013667.","DOI":"10.1002\/art.39938"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"D\u00f6ring Y, Soehnlein O, Weber C. Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis. Circulation Research. 2017; 120: 736\u2013743.","DOI":"10.1161\/CIRCRESAHA.116.309692"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Zhang S, Diao J, Qi C, Jin J, Li L, Gao X, et al. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis. BMC Cardiovascular Disorders. 2018; 18: 75.","DOI":"10.1186\/s12872-018-0812-6"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Ate\u015f AH, Aytemir K, Ko\u00e7yi\u011fit D, Yalcin MU, G\u00fcrses KM, Yorgun H, et al. Association of Neutrophil-to-Lymphocyte Ratio with the Severity and Morphology of Coronary Atherosclerotic Plaques Detected by Multidetector Computerized Tomography. Acta Cardiologica Sinica. 2016; 32: 676\u2013683.","DOI":"10.6515\/acs20160225a"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Jickling GC, Liu D, Ander BP, Stamova B, Zhan X, Sharp FR. Targeting neutrophils in ischemic stroke: translational insights from experimental studies. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 2015; 35: 888\u2013901.","DOI":"10.1038\/jcbfm.2015.45"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Pasalic L, Wang SSY, Chen VMY. Platelets as Biomarkers of Coronary Artery Disease. Seminars in Thrombosis and Hemostasis. 2016; 42: 223\u2013233.","DOI":"10.1055\/s-0036-1572328"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Li XT, Fang H, Li D, Xu FQ, Yang B, Zhang R, et al. Association of platelet to lymphocyte ratio with in-hospital major adverse cardiovascular events and the severity of coronary artery disease assessed by the Gensini score in patients with acute myocardial infarction. Chinese Medical Journal. 2020; 133: 415\u2013423.","DOI":"10.1097\/CM9.0000000000000650"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Li J, Wang X, Jia W, Wang K, Wang W, Diao W, et al. Association of the systemic immuno-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with diabetic microvascular complications. Frontiers in Endocrinology. 2024; 15: 1367376.","DOI":"10.3389\/fendo.2024.1367376"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research. 2014; 20: 6212\u20136222.","DOI":"10.1158\/1078-0432.CCR-14-0442"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Yang YL, Wu CH, Hsu PF, Chen SC, Huang SS, Chan WL, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. European Journal of Clinical Investigation. 2020; 50: e13230.","DOI":"10.1111\/eci.13230"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Liu Y, Ye T, Chen L, Jin T, Sheng Y, Wu G, et al. Systemic immune-inflammation index predicts the severity of coronary stenosis in patients with coronary heart disease. Coronary Artery Disease. 2021; 32: 715\u2013720.","DOI":"10.1097\/MCA.0000000000001037"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Zhao J, Lv H, Yin D, Zhou X, Zhu H, Guo L, et al. Systemic Immune-Inflammation Index Predicts Long-Term Outcomes in Patients with Three-Vessel Coronary Disease After Revascularization: Results from a Large Cohort of 3561 Patients. Journal of Inflammation Research. 2022; 15: 5283\u20135292.","DOI":"10.2147\/JIR.S385990"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Karakayali M, Altunova M, Yakisan T, Aslan S, Omar T, Artac I, et al. The Relationship between the Systemic Immune-Inflammation Index and Ischemia with Non-Obstructive Coronary Arteries in Patients Undergoing Coronary Angiography. Arquivos Brasileiros De Cardiologia. 2024; 121: e20230540.","DOI":"10.36660\/abc.20230540"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Ke J, Wu K, Liu X, Qiu H, Liu Q, Song J, et al. Impact of systemic immune-inflammation index and systemic inflammation response index on all-cause and cause-specific mortality: a community-based cohort study. Frontiers in Medicine. 2026; 13: 1784058.","DOI":"10.3389\/fmed.2026.1784058"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Genc O, Yildirim A, Erdogan A, Ibisoglu E, Guler Y, Capar G, et al. Modification, validation and comparison of Naples prognostic score to determine in-hospital mortality in ST-segment elevation myocardial infarction. European Journal of Clinical Investigation. 2025; 55: e14332.","DOI":"10.1111\/eci.14332"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Wang S, Zhang G. Association Between Systemic Immune-Inflammation Index and Adverse Outcomes in Patients With Acute Coronary Syndrome: A Meta-Analysis. Angiology. 2025; 76: 946\u2013954.","DOI":"10.1177\/00033197241263399"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Adali MK, Buber I, Sen G, Yilmaz S. Relationship between Systemic Immune-Inflammation Index and Coronary Collateral Circulation in Patients with Chronic Total Occlusion. Arquivos Brasileiros De Cardiologia. 2022; 119: 69\u201375.","DOI":"10.36660\/abc.20210414"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Allahwala UK, Khachigian LM, Nour D, Ridiandres A, Billah M, Ward M, et al. Recruitment and maturation of the coronary collateral circulation: Current understanding and perspectives in arteriogenesis. Microvascular Research. 2020; 132: 104058.","DOI":"10.1016\/j.mvr.2020.104058"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Liu T, Wu Z, Liu J, Lv Y, Li W. Metabolic syndrome and its components reduce coronary collateralization in chronic total occlusion: An observational study. Cardiovascular Diabetology. 2021; 20: 104.","DOI":"10.1186\/s12933-021-01297-4"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Bessueille L, Magne D. Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes. Cellular and Molecular Life Sciences: CMLS. 2015; 72: 2475\u20132489.","DOI":"10.1007\/s00018-015-1876-4"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Xu M, Chen R, Liu L, Liu X, Hou J, Liao J, et al. Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: The Dongfeng-Tongji cohort study. Atherosclerosis. 2021; 323: 20\u201329.","DOI":"10.1016\/j.atherosclerosis.2021.02.012"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Montezano AC, Dulak-Lis M, Tsiropoulou S, Harvey A, Briones AM, Touyz RM. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. The Canadian Journal of Cardiology. 2015; 31: 631\u2013641.","DOI":"10.1016\/j.cjca.2015.02.008"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Ma M, Wu K, Sun T, Huang X, Zhang B, Chen Z, et al. Impacts of systemic inflammation response index on the prognosis of patients with ischemic heart failure after percutaneous coronary intervention. Frontiers in Immunology. 2024; 15: 1324890.","DOI":"10.3389\/fimmu.2024.1324890"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. The New England Journal of Medicine. 2017; 377: 1119\u20131131.","DOI":"10.1056\/NEJMoa1707914"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. The New England journal of medicine. 2019; 381: 2497\u20132505.","DOI":"10.1056\/NEJMoa1912388"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Lavie CJ, Ozemek C, Carbone S, Katzmarzyk PT, Blair SN. Sedentary Behavior, Exercise, and Cardiovascular Health. Circulation Research. 2019; 124: 799\u2013815.","DOI":"10.1161\/CIRCRESAHA.118.312669"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/9\/10.31083\/RCM52837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:57:21Z","timestamp":1790693841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/9\/10.31083\/RCM52837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2153-8174(26)04679-0"],"URL":"https:\/\/doi.org\/10.31083\/rcm52837","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"article-number":"52837"}}